FundedIQ

Corporate Round Funded Startups in Israel

Across the 10 most recent corporate rounds listed for Israel, the only disclosed large check is CathWorks’ $75M round on 2022-07-12; the next-largest discl…

Across the 10 most recent corporate rounds listed for Israel, the only disclosed large check is CathWorks’ $75M round on 2022-07-12; the next-largest disclosed amount is CytoReason at $20M (2022-09-20), while other disclosed figures cluster near the bottom of the range ($4M Captain’s Eye on 2022-06-28; $3M Vensica Medical on 2022-02-07; two entries at $100K on 2022-02-09).

Date-wise, the disclosed and undisclosed entries concentrate in a mid-2022 window: 6 of the 10 rounds fall between 2022-06-15 and 2022-08-02 (Squalus Medical, StoreDot, CathWorks, Captain’s Eye, Prisma Photonics, and CytoReason). Sector-wise, Health Care appears 3 times (CathWorks, Squalus Medical, Vensica Medical), while Agriculture and Farming also appears 2 times (FarmSee and CropX). Geography is consistently Israel-based, with repeated urban mentions in the Tel Aviv area across different sectors (e.g., CytoReason in Tel Aviv on 2022-09-20; StoreDot in Herzliya on 2022-05-24; Prisma Photonics in Tel Aviv on 2022-08-02).

Most recent rounds

10 shown

Related listings

Frequently asked

What’s the largest disclosed corporate round in this Israel list, and how much bigger is it than the rest?

CathWorks’ $75M round (2022-07-12) is the only disclosed amount above $50M, and it dwarfs the next-largest disclosed check: CytoReason’s $20M (2022-09-20). Other disclosed rounds shown are $4M (Captain’s Eye, 2022-06-28), $3M (Vensica Medical, 2022-02-07), and $100K twice (CropX and Innovopro, both 2022-02-09).

Do the rounds cluster in time, or are they evenly spread across 2022?

They cluster around mid-2022: 6 of 10 rounds occur between 2022-06-15 and 2022-08-02, including CathWorks (2022-07-12), Captain’s Eye (2022-06-28), Squalus Medical (2022-06-15), Prisma Photonics (2022-08-02), and StoreDot (2022-05-24 is just outside but adjacent to the same run). The earliest date shown is 2022-02-07 (Vensica Medical), while the most recent is 2022-10-19 (FarmSee).

Which sectors are most represented among these corporate rounds?

Health Care is the only sector category shown 3 times: CathWorks (2022-07-12, $75M), Squalus Medical (2022-06-15, undisclosed), and Vensica Medical (2022-02-07, $3M). Agriculture and Farming appears 2 times (FarmSee on 2022-10-19, CropX on 2022-02-09 at $100K), while the remaining categories shown appear once each.

How concentrated are the listed rounds by disclosed amount versus undisclosed?

Disclosed amounts appear in 5 of the 10 rows (CytoReason $20M on 2022-09-20; CathWorks $75M on 2022-07-12; Captain’s Eye $4M on 2022-06-28; CropX $100K and Innovopro $100K on 2022-02-09; Vensica Medical $3M on 2022-02-07). The other 5 entries are undisclosed, including FarmSee (2022-10-19) and Prisma Photonics (2022-08-02).

Are there any geography patterns or standout city-level repeats?

The list is fully Israel-based, and Tel Aviv-area locations show up repeatedly across different sectors: Tel Aviv is explicitly listed for CytoReason (2022-09-20, $20M) and Prisma Photonics (2022-08-02, undisclosed), while Herzliya is used for StoreDot (2022-05-24, undisclosed). Other cities appear once in this 10-row slice (e.g., Kfar Saba for CathWorks on 2022-07-12; Haifa for Captain’s Eye on 2022-06-28).

Which entries closed most recently in this set, and do they differ in disclosed sizing?

The two latest dates shown are FarmSee on 2022-10-19 (undisclosed) and CytoReason on 2022-09-20 ($20M). After that, the next disclosed size jump is CathWorks at $75M (2022-07-12), while the later-2022 period includes at least two undisclosed rounds (FarmSee and Prisma Photonics on 2022-08-02), indicating mixed disclosure even near the top of the timeline.

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.